This inventor holds 2 USPTO granted patents. Top assignee: Hewlett-Packard Development Company, L.p.. Active years: 2008-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2013
Title: Bryan J Johnson: Innovator in Blood Analysis Technologies
Introduction
Bryan J Johnson is a notable inventor based in San Diego, CA. He has made significant contributions to the field of blood analysis, holding 2 patents that focus on innovative methods for measuring glycated hemoglobin and analyzing blood samples. His work has the potential to enhance diagnostic processes in medical settings.
Latest Patents
One of Johnson's latest patents is titled "Systems and methods for measuring glycated hemoglobin." This invention outlines a method that involves establishing multiple age-specific groups of red blood cells and measuring HbA levels within these groups. In another embodiment, the system includes a separating device designed to categorize red blood cells into these age-specific groups, along with a measuring device to assess HbA levels. Another significant patent is the "Method of analyzing blood," which describes a process that includes delivering a blood sample to a test device, applying a spatially varying electric field to create a depleted cell concentration, and sensing a property of the blood sample.
Career Highlights
Bryan J Johnson is currently associated with Hewlett-Packard Development Company, L.P., where he continues to innovate in the field of medical technology. His work is characterized by a commitment to improving health diagnostics through advanced methodologies.
Collaborations
Johnson has collaborated with notable colleagues, including David Alvin Tyvoll and Kirk W Norton, who share his passion for innovation in medical technologies.
Conclusion
Bryan J Johnson's contributions to blood analysis technologies exemplify the impact of innovative thinking in healthcare. His patents not only advance the field but also hold promise for improving patient outcomes through better diagnostic tools.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
